Sterling Consolidated Corp. STCC
Last Post: 11/29/2018 11:18:53 AM
Board Marks: 4
Posts Today: 0
Board Views Today: 183
11/29/2018 11:18:53 AM
07/20/2018 3:49:34 PM
07/13/2018 9:33:37 AM
06/29/2018 9:36:03 AM
06/25/2018 11:30:01 AM
06/22/2018 9:59:02 AM
06/21/2018 10:15:16 AM
06/15/2018 10:42:58 AM
06/15/2018 10:39:44 AM
05/31/2018 11:07:43 AM
05/22/2018 9:39:38 AM
05/17/2018 8:59:28 AM
05/14/2018 10:08:19 AM
04/26/2018 9:35:25 AM
04/20/2018 4:08:12 PM
04/19/2018 9:07:10 AM
04/18/2018 10:19:51 AM
03/15/2018 1:49:39 PM
03/08/2018 7:35:11 PM
02/16/2018 10:48:15 AM
02/15/2018 12:08:29 PM
12/31/2017 1:25:07 PM
08/16/2017 3:07:10 PM
08/16/2017 3:01:59 PM
08/16/2017 2:56:03 PM
08/14/2017 1:42:57 PM
08/14/2017 1:41:34 PM
08/14/2017 1:40:25 PM
08/14/2017 1:37:41 PM
08/14/2017 1:36:07 PM
08/14/2017 1:34:07 PM
08/10/2017 2:43:32 PM
08/10/2017 2:40:38 PM
08/10/2017 2:38:58 PM
08/10/2017 2:27:58 PM
08/10/2017 2:20:59 PM
08/09/2017 6:25:26 PM
08/09/2017 6:21:46 PM
08/09/2017 5:43:16 PM
08/08/2017 1:31:18 PM
08/08/2017 1:26:58 PM
08/08/2017 1:24:18 PM
08/01/2017 4:41:03 PM
08/01/2017 4:39:27 PM
07/27/2017 4:21:24 PM
07/27/2017 4:10:53 PM
07/27/2017 4:09:43 PM
07/27/2017 3:52:00 PM
07/26/2017 4:03:05 PM
07/26/2017 4:01:43 PM
Recent Articles
- Insights on the Upcoming Financial Street Forum in Beijing
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
- Faraday Future's Vision: Accelerating Towards FX Super One Launch
- IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
- Clover Biopharmaceuticals Names Nicholas Jackson as President
- Dr. Luke Wainscoat Brings Expertise to The Brattle Group
- Kering and L'Oréal Unite to Transform Luxury Beauty Sector
- Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
- Kering Partners with L'Oréal to Transform Luxury Beauty Sector
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer
- Vivace Therapeutics Reports Promising Results for VT3989 Therapy
- iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
- Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
- New Breakthrough Data from Novartis on Prostate Cancer Treatment
- Transforming Assets: The Role of NB HASH in Digital Wealth
- The Future of Wealth: Bridging Real-World Assets with Blockchain
- Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
- Significant Phase 1a Trial Findings for Faridoxorubicin
- Major Developments in AI: Insights from Top Tech Executives
- Celebrating Five Years of Innovations at United Imaging's Hub
